Celebrity Cannabis Brands: The Real Survival Rate
Photo by Cova Software via Unsplash.
Every few months, it's a new name on a pre-roll box. A rapper, an athlete, a sitcom actor, someone's reality-TV ex — all of them suddenly have a strain, a vape line, or an eighth with their face on it. The launch parties look the same, the press releases hit the same trade outlets, and then, more often than not, the brand just quietly stops showing up on dispensary shelves a year or two later. Nobody writes that follow-up story.
Above Board, a firm that runs mystery-shopping and retail audits across the legal cannabis market, decided to actually chase that follow-up. Its State of Celebrity Cannabis Brands report, shared with Forbes in April 2026, tracked 83 celebrity-attached cannabis brands across North America and checked which ones were still alive. Fewer than half were. The report's real value isn't the mortality rate itself — it's that the split between the survivors and the ghosts wasn't random at all. It came down to something almost boring: whether a real product existed before anyone called a journalist about it.
The report everyone's talking about
Above Board built its reputation doing retail audits, not brand puff pieces, and that shows in how this report was assembled. Instead of counting a launch as a launch, researchers checked whether product from each of the 83 tracked names was actually moving through real channels — cross-referencing dispensary menus, Headset point-of-sale data, and listings on Leafly and Weedmaps against whatever the brand's own website claimed. A press release announcing a partnership counted for nothing if there was no actual product anyone could buy. That distinction turned out to matter enormously, because plenty of these brands generated real media coverage without ever generating real revenue. Report author Gluck reduced the whole survival question to four yes-or-no checks: was there a real product, a real cultivation relationship, a real consumer feedback loop, and did any of that exist before the press rollout. Run the 83 brands through that filter and the split becomes almost mechanical — brands that could answer yes to all four are still on shelves in 2026, and brands that couldn't have mostly vanished. Published April 7-9, 2026, the report lands as the most current hard look anyone's taken at a category that's been operating for the better part of a decade on vibes and anecdote. Trade press has speculated about celebrity cannabis burnout before, but nobody had put a number on it. Fewer than half of 83 still operating is a real number, and it's a sobering one for anyone pitching a new celebrity tie-in to an investor this year.What separates survivors from ghosts
Photo via Pexels.
Line up the survivors and a pattern jumps out immediately. Khalifa Kush, Garcia Hand Picked, and Cheech & Chong's Cannabis Co. all had actual cultivation relationships and actual product moving before anyone staged a media rollout around them. Wiz Khalifa's strain built its name inside dispensaries and among growers before it became a merchandising story. Jerry Garcia's estate worked with cultivators who had genuine reputations in the craft-cannabis world. Cheech and Chong leaned on a brand that's been culturally embedded in stoner identity for decades, then backed it with product that actually showed up where people shop. In each case, the brand built a consumer feedback loop — people buying it, talking about it, coming back for more — before a single glossy profile ran anywhere. Compare that to the announcement-first playbook: the splashy press event, the celebrity on stage, the big partnership headline, and then months of dead air before anything hits a shelf, if it ever does. Nearly every brand that followed that sequence is sitting in the defunct column now. It's not that the celebrities weren't famous enough or the marketing wasn't slick enough. It's that cannabis consumers, it turns out, behave like consumers of literally any other packaged good. They buy what's good and what's actually available near them, not what got written up in a magazine six months ago. A famous name might get someone to pick up a jar once. It won't get them to buy it again if the product isn't there or isn't good.The high-profile flops: Monogram, More Life, and Ignite
Photo via Unsplash.
The report's list of high-profile failures reads like a highlight reel of the celebrity cannabis boom years. Jay-Z's Monogram launched in 2020 through The Parent Company with the kind of luxury packaging and media rollout that made it feel inevitable — this was going to be the brand that proved a superstar could do cannabis with real taste and real weight behind it. Jay-Z split from the company in December 2022, and by late 2024, SFGATE reported the brand had disappeared from shelves entirely. No slow fade, just gone. Drake's More Life Growth Company followed a similar arc with even more corporate backing. It was announced in 2019 alongside a partnership with Canopy Growth, complete with a named production facility in Scarborough, Ontario, and heavy press coverage treating it as a landmark deal. Canopy ended the venture in 2021, taking a C$10.3 million impairment charge, and a Canopy communications director later confirmed the divestment outright. According to Above Board's tracking, no More Life product ever actually reached a dispensary shelf. Not a limited run, not a soft launch — nothing. Dan Bilzerian's Ignite offers a different flavor of collapse. The company went public on the Canadian Securities Exchange and reportedly paid Bilzerian around $4 million a year in salary while burning through cash reserves. The stock eventually cratered to effectively nothing amid SEC and DOJ investigations. Three very different celebrities, three very different corporate structures, and the same underlying failure: money and attention flowing in before product ever flowed out.Who's actually selling: the Headset numbers
In 2025, 8 celebrity-backed cannabis brands ranked among the top sellers, matching the 8 traditional brands they outsold—highlighting celebrity brands' growing competitive edge in the market.
Numbers from the sales-tracking side back up exactly what the survival data suggests. MJBizDaily reported on March 18, 2026 that Headset analyst Mitchell Laferla's dataset covered 5,791 brands total across the tracked market — a useful reminder of just how crowded and undifferentiated most of cannabis retail actually is. Within that ocean, eight of the top-selling celebrity cannabis brands in the U.S. actually outsold traditional, non-celebrity brands in 2025. That's a meaningful result in a category people love to dismiss as gimmicky. The names populating that top-11 celebrity revenue list aren't surprising once you've seen the survival data: Cheech & Chong's, Garcia Hand Picked, Khalifa Kush — which launched all the way back in 2015 and has had a decade to build real distribution — and Tyson 2.0, which debuted in 2021 and moved fast into serious retail presence. Laferla's take on why these particular brands work lines up neatly with the four-question framework: the successful ones are genuinely, credibly linked to cannabis culture, and they stay focused on the core consumer, who's still overwhelmingly the male smoker who's been buying flower and vapes for years, not a lifestyle tourist chasing a famous name. Meanwhile, names that once dominated headlines have simply faded from the sales conversation. Jay-Z and Justin Bieber have largely disappeared from the category as the broader market has constricted. A shrinking, more competitive market punishes brands with no real foothold in cannabis culture a lot faster than a growing one does.The newest entries and what they're up against
Photo by Jeff W via Unsplash.
Two entries from spring 2026 show the two directions a new celebrity brand can take. Snoop Dogg's Death Row Cannabis expanded its lineup with new vape products in April 2026, leaning on something no marketing budget can manufacture: decades of actual, lived hip-hop cannabis credibility that predates the legal industry itself. That's a brand with cultural collateral to spend. WWE's Rob Van Dam took a different approach, announcing a wellness and hemp line in mid-May 2026 — stepping into a market that's far more crowded and far more skeptical than the one Khalifa Kush or Garcia Hand Picked walked into a decade ago. One side effect of how fast this category has turned over is that a lot of the reference material floating around online is stale. Older listicles from outlets like Herb, Oh Yeah Weed, CelebStoner, and EarthMed still rank Monogram and Ignite among the top celebrity cannabis brands to know, months or years after both effectively ceased to exist in retail. Anyone using those lists to make a buying or investing decision is working from outdated information. Whatever name attaches itself to cannabis next, it's going to face the same four-question test that separated the 2026 survivors from the ghosts: real product, real cultivation ties, real consumer feedback, and genuine credibility with the core smoker demographic — ideally established before the press tour, not after. And it's worth repeating that legal status still varies considerably by state and country, and hemp-derived products aren't treated the same as THC cannabis everywhere. Confirm your local law before assuming anything on a shelf is legal where you live.The celebrity cannabis gold rush — flush venture money, splashy launch events, public companies built around a famous face — is over. What's left in 2026 is a smaller, more disciplined field, and Above Board's numbers make that shift concrete instead of anecdotal. Fewer than half of 83 tracked brands survived, and the ones that did share a boring, unglamorous trait: they had real supply chains and real customers before they had a media narrative.
Strip away the celebrity angle entirely and the four-question test Gluck laid out isn't really about fame at all. Real product, real growers, real customer feedback, and doing all of that before you go looking for press — that's just how consumer packaged goods brands succeed generally, cannabis or otherwise. A famous name can accelerate awareness, but it's never been able to substitute for supply chain discipline, and cannabis buyers have made that abundantly clear with their wallets.
Going forward, expect fewer nine-figure launch parties and more quiet moves from people already embedded in cannabis culture — growers, longtime smokers, artists whose relationship with the plant predates their fame — rather than celebrities treating weed as an adjacent lifestyle category to license their name to. The market's thinned out enough that it can't support novelty for its own sake anymore. It rewards the people who were already doing the work.
